It’s a new age for heart failure (HF) management, with growing appreciation for its “four pillars” of drug therapy, but also, it appears, the waning status of left ventricular ejection...

NEW YORK (Reuters Health) – Pulmonary artery (PA) pressure monitoring reduced hospitalizations of obese patients with heart failure, regardless of ejection fraction (EF), in a post-hoc analysis of...

NEW YORK (Reuters Health) – Empagliflozin reduced the risk of adverse cardiovascular and renal outcomes in heart failure patients regardless of baseline NT-proBNP levels, researchers say. Empagliflozin...

A 3-month lifestyle intervention that used a step counter and regular, personalized text messages to encourage increased mobility and adherence to medications led to a substantial rise in the quality of...

The new guideline on management of heart failure (HF) from the European Society of Cardiology (ESC) seemed to bear an asterisk or footnote even before its full unveiling in the early hours of ESC Congress...

Hemodynamic guided management may reduce heart failure hospitalizations in patients with earlier stage heart failure, according to late breaking research presented in a Hot Line session today at ESC...

Medical therapy for heart failure (HF) guided by an implanted pulmonary artery pressure (PAP) sensor didn’t improve survival or risk for HF events like hospitalization over a year in a major randomized...

(Reuters Health) – Survival of elderly heart transplant recipients at five years is similar to that of younger recipients even though older adults are more likely to get organs from higher-risk donors,...

A new study is providing what researchers are calling “unique and important insights” into potential mechanisms contributing to the Takotsubo syndrome (TTS) also known as “broken heart...

A modeling study suggests a majority of adult COVID-19 hospitalizations nationwide are attributable to at least one of four pre-existing conditions: obesity, hypertension, diabetes, and heart failure,...